Related Experiment Video
Updated: Apr 29, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Hepatitis B virus genotypes: global distribution and clinical importance
1Mustafa Sunbul, Department of Infectious Diseases, School of Medicine, Ondokuz Mayis University, 55139 Samsun, Turkey.
Insights
Hepatitis B virus (HBV) genotype influences disease severity and treatment response. Determining HBV genotype is crucial for predicting chronic hepatitis B progression and guiding antiviral therapy.
Area of Science:
- Hepatology
- Virology
- Genetics
Background:
- Hepatitis B virus (HBV) causes significant global mortality from liver diseases like chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC).
- Viral factors, including viral load, genotype, and mutations, significantly impact disease progression.
- HBV's lack of reverse transcriptase proofreading leads to diverse genotypes, sub-genotypes, mutants, and recombinants.
Purpose of the Study:
- To investigate the impact of HBV genotypes on disease progression and response to antiviral treatment.
- To highlight the clinical significance of HBV genotype determination in managing CHB patients.
Main Methods:
- Review of existing literature on HBV genotypes and their clinical implications.
- Analysis of geographical distribution and pathogenic differences among 10 identified HBV genotypes.
Main Results:
- HBV genotypes exhibit distinct geographical distributions and pathogenic characteristics.
- Genotypes C and D are associated with higher risks of LC and HCC progression compared to other genotypes.
- Genotype A is linked to chronicity, while genotypes C and D show frequent viral mutations and chronicity.
Conclusions:
- Pathogenic variations among HBV genotypes explain differences in disease intensity, progression to LC, and HCC development.
- Genotype determination is essential for accurate prognosis of CHB and personalized antiviral treatment strategies.
Abstract:
At least 600000 individuals worldwide annually die of hepatitis B virus (HBV)-related diseases, such as chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC). Many viral factors, such as viral load, genotype, and specific viral mutations, are known to affect disease progression. HBV reverse transcriptase does not have a proofreading function, therefore, many HBV genotypes, sub-genotypes, mutants, and recombinants emerge. Differences between genotypes in response to antiviral treatment have been determined. To date, 10 HBV genotypes, scattered across different geographical regions, have been identified. For example, genotype A has a tendency for chronicity, whereas viral mutations are frequently encountered in genotype C. Both chronicity and mutation frequency are common in genotype D. LC and progression to HCC are more commonly encountered with genotypes C and D than the other genotypes. Pathogenic differences between HBV genotypes explain disease intensity, progression to LC, and HCC. In conclusion, genotype determination in CHB infection is important in estimating disease progression and planning optimal antiviral treatment.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Human Virome
Viruses with RNA Genomes
Viral Recombination
Infectious Diseases and Their Occurrence

